433684-23-2Relevant academic research and scientific papers
INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL
-
Page/Page column 118, (2016/04/09)
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).
ANTIOXIDANTS AND METHODS TO MAXIMIZE PERFORMANCE
-
Page/Page column 28; 29, (2016/09/22)
A method of preventing or reducing the level of degradation of an organic substrate is described, wherein a composition is formed that includes the organic substrate together with an effective amount of a sacrificial base and a diarylamine antioxidant.
Effect of single atom substitution in benzochalcogendiazole acceptors on the performance of ternary memory devices
Liu, Zhaojun,He, Jinghui,Zhuang, Hao,Li, Hua,Li, Najun,Chen, Dongyun,Xu, Qingfeng,Lu, Jianmei,Zhang, Keqin,Wang, Lihua
supporting information, p. 9145 - 9153 (2015/09/07)
Herein, three conjugated organic molecules comprised of the diethylamine donor, pyrimidine and benzochalcogenodiazole acceptors (where the chalcogen atoms are varied from O, S to Se), named PBOP, PBTP, and PBSeP, were synthesized and fabricated into resis
SUBSTITUTED DIARYLAMINES AND USE OF SAME AS ANTIOXIDANTS
-
Page/Page column 53-54, (2013/02/28)
The present invention relates to substituted heteroaromatic dianlamine compounds of Formula I and II, their pharmaceutically acceptable salts, and compositions thereof useful as antioxidants, wherein each of X, Y and Z are independently a carbon or nitrogen atom; R1 and R2 are each independently a hydrogen or an electron donating group, but are not both hydrogen, and wherein R1 and R2 are each bonded to a carbon atom in their own respective aryl ring.
